RKIP/PBP Antibody

PBP binds ATP, opioids and phosphatidylethanolamine. Has lower affinity for phosphatidylinositol and phosphatidylcholine. It is a serine protease inhibitor which inhibits thrombin, neuropsin and chymotrypsin but not trypsin, tissue type plasminogen activator and elastase (by similarity). PBP may be involved in the function of the presynaptic cholinergic neurons of the central nervous system. It increases the production of choline acetyltransferase but not acetylcholinesterase. It seems to be mediated by a specific receptor (by similarity).

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

We have publications tested in 1 confirmed species: Human.

We have publications tested in 1 application: Flow Cytometry.

Showing Publications 1 - 2 of 2.

Publications using NB100-1020	Applications	Species
Hleihel R, Skayneh H, de The H et al. Primary cells from patients with adult T cell leukemia/lymphoma depend on HTLV-1 Tax expression for NF-kB activation and survival Research Square 2023-03-08 [PMID: 37137914] (Flow Cytometry, Human)	Flow Cytometry	Human
Yeung K, Seitz T, Li S et al. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 1999-09-09 [PMID: 10490027]

Array NB100-1020

• RKIP/PBP Antibodies
• RKIP/PBP ELISA Kits
• RKIP/PBP Lysate
• RKIP/PBP Proteins